Aurobindo Pharma shares in focus after Q3 profit drops 10% YoY. Should you buy or sell?
Aurobindo Pharma’s Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales ...